We showed that high expression of SCAN-TFs (SCAND1, SCAND2, and MZF1) were predictive biomarkers of enhanced prognoses for patients suffering from pancreatic cancer and head and neck cancers (Figure 8 and Figure 9). The gene discussed is MZF1; the disease is familial pancreatic carcinoma.